192 filings
Page 9 of 10
6-K
yyhuulb2qbhad21 et
4 Aug 21
MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology
12:00am
6-K
uyu34zc5cryc
28 Jul 21
MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT
11:35am
6-K
8x3 88a5ccwivflf
13 Jul 21
MindMed Chosen to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit
8:40am
6-K
n4py04um
8 Jul 21
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company
5:25pm
6-K
c8cpoi72a8v
24 Jun 21
MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board
8:21am
6-K
mv2bn7rq
21 Jun 21
MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board
6:19am
S-8 POS
ol5 vlzge27o4k
15 Jun 21
Registration of securities for employees (post-effective amendment)
4:02pm
6-K
zxx0x eci
9 Jun 21
MindMed Announces Chief Executive Officer Transition
8:27am
6-K
n7ent3lcv7y8v8
28 May 21
Annual and Special Meeting of Shareholders
4:23pm
6-K
1qxce8yywd
28 May 21
Mindmed Announces Shareholder Meeting Results
12:00am
6-K
entbt7jt
26 May 21
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing
12:56pm
6-K
ydu tcs12etwkh
25 May 21
MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System
8:11am
6-K
g181560f k10ddz
20 May 21
MindMed Announces the Approval of Mescaline Study
3:17pm
6-K
5jos2a
19 May 21
The Chopra Foundation and MindMed Enter Into Letter of Intent to Partner on the Future of Psychedelic Medicines & Mental Wellbeing
12:00am
6-K
b57snq433n
18 May 21
MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial
12:00am
6-K
2d5eb6df5a319km
14 May 21
Mindmed Announces Appointment of DR. Sarah Y. Vinson As Additional Director
5:13pm
6-K
2a8g mgrsgxygqt6zx
13 May 21
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
1:12pm
6-K
wovqu2w
6 May 21
MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics
11:35am
6-K
mty47 nky1y05
28 Apr 21
Current report (foreign)
6:16am
6-K
3yihn6o vyr4lf2yzicp
27 Apr 21
MindMed Begins Trading on Nasdaq
10:52am